DarioHealth Corp.

DarioHealth Corp. announced that the temporary medical leave of absence for Steven Nelson, its President and Chief Commercial Officer, has been extended for an indefinite period. During his absence, Mr. Nelson's responsibilities will be managed by the Company's senior management team.

DarioHealth Corp. reported a net loss of $8.25 million for the first quarter of 2026, an improvement from $9.23 million in the prior year. However, the company disclosed substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows. Total revenues for the quarter decreased to $5.58 million, with a decline in services revenue partially offset by an increase in consumer hardware revenue. Cash and cash equivalents significantly decreased to $14.98 million by the end of the period.

DarioHealth Corp. announced the appointment of John R. Palumbo to its Board of Directors, effective April 10, 2026. Mr. Palumbo, 75, brings over four decades of healthcare operating experience, including guiding companies through transformative growth and IPOs. His extensive background is expected to provide valuable expertise to the company's strategic direction.